PAVmed (PAVM) EBT Growth (1y) (2017 - 2025)
PAVmed (PAVM) EBT Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | 5.78% |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn | 74.66% |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -27.02% |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 103.34% |
| 10 | PAVmed | 11.18 Mn | 9.64 Mn | -4,000.00 | -341.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -341.42% |
| Jun 30, 2025 | 17.37% |
| Mar 31, 2025 | 200.60% |
| Dec 31, 2024 | 106.56% |
| Jun 30, 2024 | 16.64% |
| Mar 31, 2024 | 16.67% |
| Dec 31, 2023 | 29.16% |
| Sep 30, 2023 | 27.34% |
| Jun 30, 2023 | 38.52% |
| Mar 31, 2023 | -13.15% |
| Dec 31, 2022 | -24.86% |
| Sep 30, 2022 | -118.99% |
| Jun 30, 2022 | -129.68% |
| Mar 31, 2022 | -94.19% |
| Dec 31, 2021 | -112.54% |
| Sep 30, 2021 | -132.69% |
| Jun 30, 2021 | -116.80% |
| Mar 31, 2021 | 32.20% |
| Dec 31, 2020 | -41.27% |
| Sep 30, 2020 | -79.58% |